News

For all press inquiries, please email cucancercomms@cumc.columbia.edu and a member of our team will get back to you.

Led by HICCC member Dr. Alexander Melamed, a new study published in JAMA Oncology confirms that minimally invasive surgery for early-stage cervical cancer is linked to higher rates of recurrence and death compared with open surgery.
Read More >
Two new pilot grants awarded by the Herbert Irving Comprehensive Cancer Center and Columbia Engineering are combining the strengths of cancer and engineering disciplines to problem solve the disease.
Read More >
The Oncology Precision Therapeutics and Imaging Core (OPTIC) provides researchers access to a broad range of in vivo imaging technologies that can help advance our understanding of how cancer progresses, and accelerate translational research by visualizing drug effects.
Read More >
Two years ago, patient Jenna Strickland overcame a battle that at times she did not think she could win: non-Hodgkin lymphoma, and she did it with a revolutionary treatment known as T-cell immunotherapy.
Read More >
New data reported by HICCC researchers at ASCO concluded that more frequent mammographic screening among early-stage breast cancer patients might not confer additional benefit at the expense of potential harm.
Read More >
In a new study, a multi-disciplinary team led by investigators at Columbia University Irving Medical Center has unraveled the epigenomic underpinnings of the Warburg effect in glioblastoma, honing in on two potential therapeutic targets that starve glioblastoma cells and keep them from growing.
Read More >
May 31, 2020
Front Page

Member Spotlight: Shawn Liu, PhD

Meet new member Dr. Shawn Liu whose lab studies the role of epigenome in normal physiology and human diseases, including cancer. Dr. Liu joins the HICCC from the Whitehead Institute at MIT, and here we learn more about his current research activities as he settles into his new home at Columbia.
Read More >

Pages